SaNOtize is an innovative biotech company, using a patented platform technology for topical delivery of NO, to treat upper respiratory and topical infections

SaNOtize addresses antimicrobial resistance epidemic using its proprietary NORS technology, which allows for the effective topical delivery of nitric oxide as an alternative to antibiotics in the treatment of a variety of infections caused by fungus, bacteria, and viruses.